| Tetrathiomolybdate in Hormone Refractory Prostate Cancer (NCT00150995) | University of Michigan Rogel Cancer Center | 2001-05-01 |
| Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma (NCT00143871) | University of Michigan Rogel Cancer Center | 2001-04-01 |
| Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma (NCT00176774) | University of Michigan Rogel Cancer Center | 2001-02-01 |
| Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome (NCT00005598) | University of Michigan Rogel Cancer Center | 2000-10-01 |
| Radiation Therapy With Capecitabine in Rectal Cancer (NCT00176787) | University of Michigan Rogel Cancer Center | 2000-10-01 |
| Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer (NCT00151034) | University of Michigan Rogel Cancer Center | 2000-09-01 |
| UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer (NCT00900094) | University of Michigan Rogel Cancer Center | 2000-06-01 |
| Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood (NCT00146055) | University of Michigan Rogel Cancer Center | 2000-03-01 |
| Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood (NCT00143884) | University of Michigan Rogel Cancer Center | 2000-03-01 |
| Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine (NCT00176761) | University of Michigan Rogel Cancer Center | 2000-03-01 |
| Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder (NCT00136175) | University of Michigan Rogel Cancer Center | 1999-11-01 |
| Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer (NCT00148070) | University of Michigan Rogel Cancer Center | 1999-03-01 |
| UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer (NCT00146042) | University of Michigan Rogel Cancer Center | 1999-03-01 |
| UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia (NCT00003598) | University of Michigan Rogel Cancer Center | 1999-01-01 |
| Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate (NCT00151060) | University of Michigan Rogel Cancer Center | 1998-12-01 |
| Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma (NCT00230451) | University of Michigan Rogel Cancer Center | 1997-11-01 |
| Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers (NCT00141765) | University of Michigan Rogel Cancer Center | 1997-01-01 |
| Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus (NCT00003076) | University of Michigan Rogel Cancer Center | 1995-10-01 |
| Companion Pharmacogenetic Study to UMCC 9900/9901 (NCT00146029) | University of Michigan Rogel Cancer Center | |
| A Phase II Trial Evaluating WNT974 in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (NCT02649530) | University of Michigan Rogel Cancer Center | |